Triple

T19992626
Position Surface form Disambiguated ID Type / Status
Subject APOE gene E494100 entity
Predicate protectiveAlleleForDisease P138240 FINISHED
Object APOE ε2 NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: APOE ε2 | Statement: [APOE gene, protectiveAlleleForDisease, APOE ε2]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: APOE ε2
Context triple: [APOE gene, protectiveAlleleForDisease, APOE ε2]
  • A. APOE ε2 chosen
    APOE ε2 is a common apolipoprotein E gene variant associated with a reduced risk of late-onset Alzheimer’s disease but an increased risk of type III hyperlipoproteinemia.
  • B. APOE ε3 allele
    The APOE ε3 allele is the most common and generally considered the “neutral” variant of the apolipoprotein E gene, associated with average risk for Alzheimer’s disease and typical lipid metabolism compared to other APOE alleles.
  • C. APOE ε4 allele
    The APOE ε4 allele is a genetic variant of the apolipoprotein E gene that significantly increases an individual's susceptibility to late-onset Alzheimer's disease.
  • D. APOE gene
    The APOE gene encodes apolipoprotein E, a key protein in lipid metabolism whose variants, especially ε4, strongly influence risk for Alzheimer’s disease and cardiovascular disorders.
  • E. APO-E
    APO-E is a protein encoded by the APOE gene that plays a key role in lipid transport and is strongly associated with risk for Alzheimer’s disease and cardiovascular disorders.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: protectiveAlleleForDisease
Context triple: [APOE gene, protectiveAlleleForDisease, APOE ε2]
  • A. geneticallyLinkedTo
    Indicates a relationship where two entities share a genetic connection, such as common ancestry, shared genes, or hereditary association.
  • B. associatedWithPhenotype
    Indicates that an entity has a documented connection or correlation with a particular phenotype or observable trait.
  • C. hasGeneticLocus
    Indicates that a genetic feature or trait is located at, or associated with, a specific position (locus) on a genome or chromosome.
  • D. geneticAffinity
    Indicates a relationship where entities share a notable degree of genetic similarity or relatedness.
  • E. geneticStatus
    Indicates the genetic condition or variant state an entity has in relation to a specific gene or set of genes.
  • F. None of above. chosen

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69da626a67648190af9653832a3aeced completed April 11, 2026, 3:02 p.m.
NER Named-entity recognition batch_69e65fe10ffc81908c94168b0a8ea9c9 completed April 20, 2026, 5:18 p.m.
PD Predicate disambiguation batch_69e537fd311881908448f2aea8b4812e completed April 19, 2026, 8:15 p.m.
PDg Predicate description generation batch_69e543c42c688190a22f4d31ec692377 completed April 19, 2026, 9:06 p.m.
Created at: April 11, 2026, 3:31 p.m.